Q2 2021 Holdings
Filed 2021-08-16 | 112 holdings | $790.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $167.2M | 1,484,400 | 21.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $142.8M | 1,854,000 | 18.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $112.9M | 3,180,000 | 14.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $63.7M | 183,900 | 8.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $54.8M | 751,200 | 6.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $41.1M | 673,400 | 5.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $40.2M | 2,621,000 | 5.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $38.2M | 1,000,000 | 4.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $33.1M | 195,000 | 4.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $29.4M | 1,003,522 | 3.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $22.9M | 940,000 | 2.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $16.4M | 1,450,000 | 2.1% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $9.3M | 1,395,000 | 1.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $8.6M | 104,000 | 1.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $4.8M | 200,000 | 0.6% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $2.4M | 100,000 | 0.3% |
| Vertex Pharmaceuticals Inc.(VRTX) | COM | 92532F100 | $191.5K | 950,000 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $129.8K | 565,500 | 0.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $123.7K | 2,963,545 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $121.6K | 753,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $114.9K | 2,160,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $101.0K | 640,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $85.7K | 882,500 | 0.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $80.7K | 1,208,800 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $79.2K | 4,615,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $78.6K | 2,750,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $73.3K | 590,000 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $66.4K | 535,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $66.3K | 681,000 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $64.9K | 6,966,376 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $64.3K | 943,000 | 0.0% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $61.7K | 1,367,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $61.5K | 380,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $61.2K | 729,000 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $58.4K | 540,000 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $56.2K | 1,940,200 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $53.2K | 568,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $49.5K | 563,200 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $49.5K | 436,000 | 0.0% |
| Sotera Health Co(SHC) | COM | 83601L102 | $46.3K | 1,910,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $45.0K | 358,500 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $43.4K | 2,070,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $42.4K | 236,400 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $39.8K | 4,105,000 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $38.7K | 1,808,394 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $37.3K | 654,200 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $36.0K | 9,294,600 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $33.5K | 3,400,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $32.7K | 1,150,050 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $31.3K | 1,524,998 | 0.0% |